A novel cytogenetic abnormality in Burkitt lymphoma associated with treatment resistant disease

Clinical and Laboratory Haematology

Volumn 27, Issue 5, 2005, Pages 328-330

  Durant, E ^a   Diaz, S ^b   Greenaway, S ^a   Smith, A ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

CMYC; Deletion; Fluorescence in situ hybridization; Immunoglobulin H; t(8,14)

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

BURKITT LYMPHOMA; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETIC ANALYSIS; FATAL OUTCOME; GENE DELETION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC; TREATMENT FAILURE;

EID: 26044479192     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00706.x     Document Type: Article

References (12)

1. Borkhardt A., Harbott J. & Lampert F. (1999) Biology and clinical significance of the TEL/AML1 rearrangement. Current Opinion in Pediatrics 11, 33-38.
2. Chapman C., Mockridge I., Rowe M., Rickinson A. & Stevenson F. (1995) Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 85, 2176-2181.
3. Hoelzer D., Ludwig W.D., Thiel E., Gassmann W., Loffler H., Fonatsch C., Rieder H., Heil G., Heinze B., Arnold R., Hossfeld D., Buchner T., Koch P., Freund M., Hiddemann W., Maschmeyer G., Heyll A., Aul C., Faak T., Kuse R., Ittel T.H., Gramatzki M., Diedrich H., Kolbe K., Fuhr H.-G., Fischer K., Schadeck-Gressel C., Weiss A., Strohscheer I., Metzner B., Fabry U., Gokbuget N., Volkers B., Messerer D. & Uberla K. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87, 495-508.
4. Huntly B.J., Bench A. & Green A.R. (2003) Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 102, 1160-1168.
5. Jaffe E.S., Harris N.L., Stein H. & Vardiman J.W. (eds) (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Haemopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
6. Kim D.H., Moldwin R.L., Vignon C., Bohlander S.K., Suto Y., Giordano L., Gupta R., Fears S., Nucifora G. & Rowley J.D. (1996) TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 88, 785-794.
7. Knight S.J.L., Lese C.M., Precht K.S., Kuc J., Ning Y., Lucas S., Regan R., Brenan M., Nicod A., Lawrie N.M., Cardy D., Nguyen H., Hudson T.J., Riethman H.R., Ledbetter D.H. & Flint J. (2000) An optimized set of human telomere clones for studying telomere integrity and architecture. American Journal of Human Genetics 67, 320-332.
8. Kuppers R. & Dalla-Favera R. (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogens 20, 5580-5594.
9. Sharma P., Watson N., Robson L., Gallo J. & Smith A. (1999) Novel chromosome 16 abnormality-der(16)del(16) (q13) t(16;21)(p11.2;q22)-associated with acute myeloid leukemia. Cancer Genetics & Cytogenetics 113, 25-28.
10. Siebert R., Matthiesen P., Harder S., Zhang Y., Borowski A., Zuhlke-Jenisch R., Metzke S., Joos S., Weber-Matthiesen K., Grote W. & Schlegelberger B. (1998) Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood 91, 984-990.
11. Zagaria A., Anelli L., Albano F., Storlazzi C.T., Liso A., Roberti M.G., Buquicchio C., Liso V., Rocchi M. & Specchia G. (2004) A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. Cancer Genetics & Cytogenetics 150, 81-85.
12. Zech L., Haglund U., Nilsson K. & Klein G. (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. International Journal of Cancer 17, 47-56.